Philadelphia researchers have made a significant breakthrough in understanding the side effects of obesity drugs like Ozempic. They found that priming the melanocortin system, which is involved in regulating appetite, could improve the effectiveness of these drugs and reduce their side effects, such as nausea.
GLP-1 drugs, which work by targeting the underlying dysfunctional appetite in the brain, are also being explored for their potential roles in neuroprotection, substance use disorders, and metabolic liver disease. A succinct review by DanielJ. Drucker in Science Magazine, highlighted by Eric Topol, underscores these expanded roles for GLP-1 drugs.
Dr. Nadolsky also emphasizes that GLP-1 drugs help people navigate the obesogenic environment, which is the environment that promotes obesity. By reducing appetite and controlling blood sugar levels, GLP-1 drugs can help people lose weight and keep it off, even in the face of obesogenic factors.
Did you find this Information helpful?
Thanks for your feedback!
Tags: Health, Ozempic, Diabetes
See Comments
